UnitedHealth Group Commits $1.5 Billion to AI as Q1 Results Beat Expectations

UnitedHealth Group reported stronger-than-expected first-quarter results and raised its 2026 earnings outlook, while outlining a $1.5 billion investment in artificial intelligence tied to operational improvements.

The company posted $111.7 billion in revenue for Q1, up from $109.6 billion a year earlier, and reported $6.3 billion in profit. Both figures exceeded expectations.

Its medical loss ratio (MLR), a key measure of spending on patient care, improved to 83.9% from 84.8% in the prior-year quarter. The company attributed the change to stronger cost management and favorable reserve development.

UnitedHealth now expects more than $18.25 in earnings per share for 2026, up from its previous guidance of $17.75.

CEO Stephen Hemsley said the company is focused on simplifying healthcare operations. “We are continuing to help simplify and modernize healthcare for the people and care providers we serve,” he said in the earnings release.

This approach reflects broader enterprise adoption patterns, where AI is increasingly used to reduce administrative burden and improve efficiency across healthcare systems, as seen in deployments across billing and clinical workflows.

AI Investment Anchors Operational Reset

UnitedHealth is positioning artificial intelligence as a core part of its operational strategy, committing $1.5 billion in 2026 to AI initiatives across its business.

A significant portion of that investment is directed toward OptumInsight, its data and technology unit, where legacy systems are being phased out in favor of AI-based platforms. CFO Wayne DeVeydt said the company began winding down older products in Q1, with benefits expected later in 2026.

Sandeep Dadlani, CEO of OptumInsight, said about one-third of the investment is focused on transforming the unit into an AI-first operation, with the rest targeting enterprise workflows.

These include a new AI chatbot, Avery, expected to reach 20 million members by the end of 2026, and systems designed to automate prior authorization and administrative tasks.

The company said its AI-driven prior authorization tool has shown a 96% approval rate in early deployment.

UnitedHealth expects a roughly 2:1 return on its AI investments, with many tools projected to generate returns within 12 to 18 months.

Some platforms are already operating at scale. Its OptumReal claims system processed about 500 million claims so far this year and is projected to reach 2.5 billion transactions by the end of 2026.

The company is also commercializing these tools through its Optum platforms, offering AI-enabled services to payers and providers.

Mixed Segment Performance as Membership Shifts

Performance across UnitedHealth’s business units showed uneven trends during the quarter.

UnitedHealthcare, the insurance division, generated $86.3 billion in revenue, up from $84.6 billion in the prior year. Total membership reached 49.1 million, though the company reported a decline of about 700,000 members compared to the end of 2025.

The decline included a reduction of 965,000 Medicare Advantage members, partially offset by gains of 415,000 in the commercial segment. Medicaid enrollment also fell by about 220,000 due to eligibility changes.

At Optum, revenue was $63.7 billion, slightly down from $63.9 billion a year earlier. Within the segment, Optum Health revenue declined 3%, reflecting a drop in value-based care membership.

Optum Rx reported a 2% increase in revenue, supported by growth in specialty pharmacy.

UnitedHealth is also reshaping its portfolio. The company plans to acquire Alegeus Technologies, a health tech platform, with the deal expected to close in the second half of 2026.

It also divested its Optum UK business, directing $400 million in proceeds to the United Health Foundation as part of a broader focus on its U.S. operations.

Hemsley said the company is taking a measured approach to AI deployment. “We are going to be very measured in terms of how we go about this,” he said. “But definitely, we are leaning into this.”